Chimerix Inc at JPMorgan Healthcare Conference Transcript
Good morning, and welcome to the last day of the 41st Annual JPMorgan Healthcare Conference. My name is Dave Parag, and I'm an associate part of the JPMorgan Health Care Investment Banking team.
Today, I have the pleasure of introducing Chimerix and their CEO, Mike Sherman. In the audience, we also have CTO, Dr. Joshua Allen; and CFO and CBO, Mike Andriole. Please note, there will be time for Q&A at the end of the session. A mic will be passed around for any questions that you have. Thank you, and take it away. Mike.
Thanks, Dave. It's great to be here back in person again. It's especially energizing when you've got some exciting things to talk about. So I'd love to take the opportunity to give you an update.
For those that don't know, Chimerix is an oncology-focused company headquartered in the Research Triangle in North Carolina and have a Phase III program and a mutant form of glioma that we're really excited about the data we've generated there and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |